<DOC>
	<DOCNO>NCT00154180</DOCNO>
	<brief_summary>The study examine effect estrogen progesterone development atherosclerosis menopausal woman hormone treatment initiate within 3 year menopausal transition .</brief_summary>
	<brief_title>Kronos Early Estrogen Prevention Study ( KEEPS )</brief_title>
	<detailed_description>The KEEPS design explore hypothesis early initiation hormone therapy , woman inception menopause , decrease rate accumulation atherosclerotic plaque , indicate likely delay onset clinical cardiovascular disease . The study design multicenter , 4 year randomize clinical trial . It evaluate effectiveness 0.45 mg/day oral conjugate equine estrogens 50 mcg/day transdermal estradiol via skin patch change weekly ( combination cyclic oral , micronized progesterone , 200 mg daily 12 day per month ) , versus placebo prevent progression carotid intimal medial thickness sonogram accrual coronary calcium woman age 42-58 within 36 month final menstrual period initiation treatment . A number secondary endpoint include biochemical genetic risk factor cardiovascular thrombotic disease , effect cognition also study . The study enroll total 720 woman 2005-6 , anticipated completion trial 2010 .</detailed_description>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estrogens , Conjugated ( USP )</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>menses absent least 6 month 36 month good general health plasma FSH level great equal 35 mIU/ml estradiol level &lt; 40 pg/ml normal mammogram within 1 year randomization use hormone replacement supplement within 3 month randomization endometrial thickness &gt; 5 mm vaginal ultrasound utero exposure diethylstilbestrol ( DES ) current smoking &gt; 10 cigarettes/day obesitybody mass index &gt; 35 history clinical cardiovascular disease history cerebrovascular disease history thromboembolic disease coronary calcium score â‰¥ 50 unit dyslipidemiaLDL cholesterol &gt; 190 mg/dl hypertriglyceridemiatriglycerides &gt; 400 mg/dl lipid lower medication ( statin , fibrate , &gt; 500 mg/day niacin ) nut allergy ( Prometrium include peanut oil ) uncontrolled hypertensionsystolic BP &gt; 150 and/or diastolic BP &gt; 95 hysterectomy history , prevalent , chronic disease include cancer ( basal cell skin cancer ) , renal failure , cirrhosis , diabetes mellitus , endocrinopathies adequately treat thyroid disease know HIV infection and/or medication HIV infection result safety laboratory test chemistry , ( TSH , CBC , U/A ) 20 % abnormal</criteria>
	<gender>Female</gender>
	<minimum_age>42 Years</minimum_age>
	<maximum_age>58 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Perimenopause</keyword>
	<keyword>Coronary Disease</keyword>
	<keyword>Estrogen Replacement Therapy</keyword>
	<keyword>Hormone Replacement Therapy</keyword>
</DOC>